Orexigen Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Orexigen Therapeutics's estimated annual revenue is currently $12.3M per year.
- Orexigen Therapeutics's estimated revenue per employee is $201,000
Employee Data
- Orexigen Therapeutics has 61 Employees.
- Orexigen Therapeutics grew their employee count by -3% last year.
Orexigen Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Supply Chain & Site Head | Reveal Email/Phone |
Orexigen Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Orexigen Therapeutics?
Orexigen's commitment to patients is reflected in all that we do: we are a company driven by the knowledge that our work is important and the desire to make a difference. Orexigen offers prospective employees exciting challenges, unique opportunities for career growth, and a fast-paced environment that emphasizes innovation and achievement.
keywords:N/AN/A
Total Funding
61
Number of Employees
$12.3M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Orexigen Therapeutics News
Leading Manufacturers Analysis in Global Weight Loss Therapeutics Market 2022: ? Abbott, Sanofi, Novo Nordisk, Arena Pharmaceuticals, Orexigen...
Orexigen Therapeutics, Inc. Pfizer, Inc; Sarl COUSIN BIOTECH; Technogym SpA; USGI Medical, Inc. Vivus, Inc. For more information about this...
Case study 3: Takeda Pharmaceutical- Orexigen Therapeutics. 3.4.1.b. Case study 4: Celgene - Acceleron Pharma.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.4M | 61 | 3% | $62M |
#2 | $5.8M | 63 | -7% | N/A |
#3 | $11.6M | 63 | 17% | N/A |
#4 | $17.5M | 63 | 40% | N/A |
#5 | $8.6M | 66 | -11% | N/A |